HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 281, Issue 2, 824-833, January 13, 2006

This Article Abstract Full Text (PDF) All Versions of this Article: 281/2/824    most recent M505806200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Suzuki, H. Articles by Horinouchi, S. Search for Related Content PubMed PubMed Citation Articles by Suzuki, H. Articles by Horinouchi, S. Social Bookmarking                      What's this?

A Novel o-Aminophenol Oxidase Responsible for Formation of the Phenoxazinone Chromophore of Grixazone^*

From the Department of Biotechnology, Graduate School of Agriculture and Life Sciences, University of Tokyo, Bunkyo-ku, Tokyo 113-8657, Japan

Received for publication, May 27, 2005 , and in revised form, October 19, 2005.

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
Grixazone contains a phenoxazinone chromophore and is a secondary metabolite produced by Streptomyces griseus. In the grixazone biosynthesis gene cluster, griF (encoding a tyrosinase homolog) and griE (encoding a protein similar to copper chaperons for tyrosinases) are encoded. An expression study of GriE and GriF in Escherichia coli showed that GriE activated GriF by transferring copper ions to GriF, as has been observed for a Streptomyces melanogenesis system in which the MelC1 copper chaperon transfers copper ions to MelC2 tyrosinase. In contrast with tyrosinases, GriF showed no monophenolase activity, although it oxidized various o-aminophenols as preferable substrates rather than catechol-type substrates. Deletion of the griEF locus on the chromosome resulted in accumulation of 3-amino-4-hydroxybenzaldehyde (3,4-AHBAL) and its acetylated compound, 3-acetylamino-4-hydroxybenzaldehyde. GriF oxidized 3,4-AHBAL to yield an o-quinone imine derivative, which was then non-enzymatically coupled with another molecule of the o-quinone imine to form a phenoxazinone. The coexistence of N-acetylcysteine in the in vitro oxidation of 3,4-AH-BAL by GriF resulted in the formation of grixazone A, suggesting that the –SH group of N-acetylcysteine is conjugated to the o-quinone imine formed from 3,4-AHBAL and that the conjugate is presumably coupled with another molecule of the o-quinone imine. GriF is thus a novel o-aminophenol oxidase that is responsible for the formation of the phenoxazinone chromophore in the grixazone biosynthetic pathway.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
We have long studied the A-factor regulatory cascade that leads to secondary metabolite formation and morphological differentiation in Streptomyces griseus (1, 2). The A-factor (2-isocapryloyl-3R-hydroxymethyl--butyrolactone) triggers the synthesis of almost all the secondary metabolites produced by this species. One of the secondary metabolites under the control of the A-factor is grixazone. Grixazone is a yellow pigment and actually a mixture of grixazones A and B (compounds 1a and 1b) (see Fig. 2C) (3). Grixazone A is a novel compound, and grixazone B has been reported to show a parasiticide activity (4).

Grixazones contain a phenoxazinone chromophore. The phenoxazinone skeleton is common to actinomycin D produced by Streptomyces antibioticus (5), michigazone produced by Streptomyces michiganensis (6), texazone produced by Streptomyces sp. WRAT-210 (7), exfoliazone produced by Streptomyces exfoliatus (8), and 4-demethoxymichigazone produced by Streptomyces halstedii (9). Hsieh and Jones (10) reported a phenoxazinone synthase in S. antibioticus that catalyzes the six-electron oxidative coupling of o-aminophenol compounds derived from tryptophan through 3-hydroxyanthranilic acid. However, disruption of the phenoxazinone synthase gene in S. antibioticus does not affect actinomycin D synthesis, showing that the phenoxazinone skeleton in actinomycin D is biosynthesized in vivo by a still unknown enzyme or non-enzymatically (11). On the other hand, michigazone with a hydroxymethyl group at the 8-position of the phenoxazinone and texazone with a carboxyl group at this position are assumed to be synthesized from a precursor(s) different from that of actinomycin D with no functional group at this position (7). No study on the precursor(s) or the biosynthetic enzyme for the phenoxazinone skeleton of these compounds has so far been reported. Because grixazones A and B contain an aldehyde and a carboxyl group, respectively, at the 8-position, the biosynthesis of the phenoxazinone skeleton in grixazones should be the same as those in michigazone and texazone. The phenoxazinones of exfoliazone and 4-demethoxymichigazone (which both contain a hydroxymethyl group at this position) are also presumed to be synthesized in a similar way.

We cloned the grixazone biosynthesis gene cluster and revealed the organization of the genes.²² Because all the biosynthesis and regulatory genes for a certain secondary metabolite are usually contained within the gene cluster, we expected that one of the gene products encoded in this gene cluster is responsible for the formation of the phenoxazinone skeleton of grixazones. Because some tyrosinases show an additional activity to use o-aminophenol as a substrate and yield phenoxazinones (12, 13), we aimed at two gene products (GriE and GriF) that are similar to the MelC1 and MelC2 proteins in streptomycetes, respectively. MelC2 is a tyrosinase and MelC1 is a copper chaperon for MelC2. Tyrosinase is a copper-containing monooxygenase that catalyzes two types of reaction, the o-hydroxylation of monophenols (monophenolase activity) and the oxidation of o-diphenols to o-quinone (diphenolase activity) using molecular oxygen. Tyrosinase is a member of the type 3 copper protein family, which also includes hemocyanins and catechol oxidases. The type 3 copper proteins contain a binuclear copper active site that is composed of two closely spaced copper atoms, each coordinated by three histidine residues. Although the binuclear copper active site is highly conserved, as determined by its characteristic spectroscopic signatures, by sequence homologies, and by the crystal structures of several hemocyanins and a catechol oxidase, their functions in catalysis are different. Catechol oxidases oxidize diphenols to the corresponding quinones but lack tyrosine hydroxylase activity. Hemocyanins serve as oxygen carriers and oxygen storage proteins in arthropods and mollusks. Tyrosinases are responsible for melanin pigmentation in streptomycetes, browning in plants, and melanization in animals. In addition to the intrinsic tyrosinase activities, the tyrosinases from Neurospora crassa (12), mushroom (13), and Streptomyces glaucescens (12) convert 2-aminophenols into the corresponding o-quinone imines in vitro at a lesser rate, which are then non-enzymatically converted into phenoxazinones.

In this study, we determined the plausible substrate of GriF by structural elucidation of an intermediate (3-amino-4-hydroxybenzaldehyde (3,4-AHBAL³; compound 2a) (see Fig. 2C) that accumulated in a griEF-deleted mutant and revealed the in vitro formation of a phenoxazinone skeleton from 3,4-AHBAL by recombinant GriF produced in Escherichia coli. GriF did not use tyrosine as a substrate, although it showed 50% identity in amino acid sequence to melanin-producing tyrosinases in Streptomyces. We have thus concluded that GriF is an o-aminophenol oxidase responsible for the in vivo formation of the phenoxazinone chromophore in the grixazone biosynthetic pathway.

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
Bacterial Strains, Media, and Materials—S. griseus strain IFO13350 was obtained from the Institute of Fermentation (Osaka, Japan). S. griseus strains were grown at 26.5 or 30 °C in YPD medium (0.2% yeast extract, 0.4% Bacto-peptone, 0.5% NaCl, 0.2% MgSO₄·7H₂O, 1% glucose, and 0.5% glycine, pH 7.2) and SMM medium (0.9% glucose, 0.9% asparagine, 0.2% (NH₄)₂SO₄, 0.24% Trizma (Tris base), 0.1% NaCl, 0.05% K₂SO₄, 0.02% MgSO₄·7H₂O, 0.01% CaCl₂, 0.0034% (0.25 mM) KH₂PO₄, and 1% trace element solution (14), pH 7.2). The thiostrepton resistance plasmid pIJ702, with its copy number of 40–300 (14), was used for expression of griR. E. coli strains JM109 and TOP10 (Invitrogen) and plasmids pUC19 and pCR4Blunt-TOPO (Invitrogen), pET-17b, and pET-26b were used for DNA manipulation. E. coli strain BL21(DE3)/pLysS was used for production of GriE and GriF. Restriction enzymes, T4 DNA ligase, Pyrobest DNA polymerase, and other DNA-modifying enzymes were purchased from Takara Biochemicals. DNA was manipulated in Streptomyces (14) and E. coli (15) as described. L-Tyrosine, L-3,4-dihydroxyphenylalanine, and benzoic compounds except for 3,4-AHBAL were purchased from Wako Chemicals. 3,4-AHBAL was purified from the culture supernatant of S. griseus mutant griEF-harboring pIJ702-griR (see below). The tyrosinase from mushroom was purchased from Sigma.

Deletion of griEF—The chromosomal griEF region of S. griseus IFO13350 was deleted as follows (see Fig. 1A). A 3.6-kb NcoI-SphI fragment containing a region upstream from griE and a 3.6-kb PmaCI fragment containing a 3'-portion of griF and a region downstream from griF were connected with a short linker derived from the multi-cloning linker of pUC19. This 7.2-kb fragment, which had a 1.1-kb deletion of the sequence in the griEF locus (from Met³ of GriE to His²²⁶ of GriF), was cloned into pUC19 together with a 1.1-kb HindIII fragment carrying the kanamycin resistance gene from Tn5, resulting in pgriEF. The plasmid was alkali-denatured and introduced by protoplast transformation into S. griseus IFO13350. Kanamycin-resistant transformants containing pgriEF in the chromosome (as a result of a single crossover) were first isolated, and one of the transformants was cultivated several times on YPD medium without kanamycin. Kanamycin-sensitive colonies (derived after a second crossover) were candidates for griEF-disrupted strains (mutant griEF). The correct replacement was checked by Southern hybridization using a 0.5 kb PmaCI-SphI fragment as a ³²P-labeled probe (see Fig. 1A).

Identification of 3,4-AHBAL and 3-Acetylamino-4-hydroxybenzaldehyde (3,4-AcAHBAL) in the Supernatant of S. griseus Mutant griEF— For the purpose of overproduction of grixazone and its intermediates, we placed griR under the control of the melC promoter in pIJ702. The griR-coding sequence was amplified by the following two primers, 5'-GCGCATGCCTACGCACCATC-3' (with the start codon of griR in italic letters and the SphI site underlined) and 5'-TCGAATTCTCAGCCGGAGCGCCC-3 (with the stop codon of griR in italic letters and the EcoRI site underlined). After the amplified fragment had been cloned into pCR4Blunt-TOPO and sequenced to confirm the absence of PCR-generated errors, the griR sequence was excised with SphI plus EcoRI and cloned between the SphI and EcoRI sites of a pIJ702-derived plasmid in which the melC1-melC2 sequence was replaced by a short linker containing SphI, BglII, and EcoRI sites, resulting in pIJ702-griR.

S. griseus mutant griEF-containing pIJ702-griR was cultivated at 26.5 °C with rotary shaking for 3 days in SMM medium supplemented with 10 µg/ml thiostrepton. The culture broth was cleared by centrifugation at 6000 x g for 20 min and treated with hexane for liquid-liquid distribution. The materials in the aqueous layer were extracted with ethyl acetate and dried by evaporation. The crude material was dissolved in Me₂SO and subjected to reversed-phase HPLC using a Waters 600 HPLC system equipped with a Waters 996 photodiode array detector. Compounds 2a and 2b (see Fig. 2C) were collected. HPLC conditions were as follows: column, CAPCELL PAK C₁₈ (10 x 250 mm; Shiseido Fine Chemicals); flow rate, 3 ml/min; solvent A, 0.1% (v/v) trifluoroacetic acid in water; and solvent B, 0.1% (v/v) trifluoroacetic acid in 90% (v/v) acetonitrile in water. After 100 µl of the crude material had been injected into the column equilibrated with 5% solvent B, the column was initially developed isocratically for 3 min, followed by elution with a linear gradient from 5 to 100% solvent B over 13 min. 3,4-AHBAL (compound 2a) and 3,4-AcAHBAL (compound 2b) were identified on the basis of the following spectroscopic parameters (see Fig. 2C). 3,4-AHBAL (compound 2a): ¹H NMR (500 MHz, Me₂SO-d₆) 9.63 (s, 1H, CHO), 7.10 (d, 1H, J = 2.5 Hz, ArH), 7.03 (dd, 1H, J = 8.0, 2.5 Hz, ArH), and 6.81 (d, 1H, J = 8.0 Hz, ArH); ¹³C NMR (125 MHz, Me₂SO-d₆) 191.6 (C-7), 150.7 (C-4), 137.6 (C-3), 129.3 (C-1), 122.4 (C-6), 114.0 (C-2), and 112.5 (C-5); high resolution electrospray ionization time-of-flight mass spectrum, m/z 137.09312 [M]⁺ (calculated for C₇H₇N₁O₂, 2.39 mmu error). 3,4-AcAHBAL (compound 2b): ¹H NMR (500 MHz, Me₂SO-d₆) 11.12 (s, 1H, OH), 9.76 (s, 1H, CHO), 9.34 (s, 1H, NH), 8.41 (d, 1H, J = 2.0 Hz, ArH), 7.53 (dd, 1H, J = 8.5 Hz, 2.0, ArH), 7.03 (d, 1H, J = 8.0 Hz, ArH), and 2.12 (s, 3H, CH₃); ¹³C NMR (125 MHz, Me₂SO-d₆) 191.3 (C-7), 169.2 (C-8), 153.6 (C-4), 128.3 (C-3), 127.7 (C-6), 127.2 (C-1), 122.6 (C-2), 115.4 (C-5), and 23.8 (C-9); high resolution electrospray ionization time-of-flight mass spectrum, m/z 180.06632 [M + H]⁺ (calculated for C₉H₁₀N₁O₃, 0.25 mmu error).

Expression of griE and griF in E. coli—The griF sequence was amplified by PCR with two primers, 5'-CATATGGTCCACGTACGCAAG-3' (with the start codon of griF in italic letters and the NdeI site underlined) and 5'-CTCGAGCTGGTCGTAGGTGTAGAAC-3 (with the XhoI site underlined). After the amplified fragment had been cloned into pCR4Blunt-TOPO and sequenced to confirm the absence of errors during PCR, the griF sequence was excised with NdeI and XhoI and cloned into pET-26b(+). The griF sequence, together with the lacI gene, was excised from the plasmid by digestion with Bpu1102I and Bst1107I and transferred onto pET-17b digested with Bpu1102I and Bst1107I, resulting in pET-griF, which contained griF under the control of the T7/lac promoter. The griE sequence was amplified by PCR with primers 5'-CATATGCCCATGAACAGGCGAG-3' (with the start codon of griE in italic letters and the NdeI site underlined) and 5'-CTCGAGTCAGAGGTGCGTGACGTG-3 (with the stop codon of griE in italic letters and the XhoI site underlined). The amplified fragment was cloned into pCR4Blunt-TOPO and sequenced to confirm the absence of errors during PCR. The griE sequence was excised with NdeI and XhoI and cloned in pET-17b, resulting in pET-griE, which contained griE under the control of the T7 promoter. For construction of plasmid containing both griE and griF, pET-griF was digested with SphI and treated with T4 DNA polymerase to produce blunt ends, followed by BglII digestion. To this linear plasmid with a BglII site at one end and a blunt end at the other end, a 0.9-kb fragment containing the griE expression cassette excised from pET-griE by digestion with SspI and BglII was ligated, resulting in pET-griEF, which contained griE under the control of the T7 promoter and griF under the control of the T7/lac promoter. These plasmids were used to transform E. coli BL21(DE3)/pLysS cells. Transformant cells were cultured at 26.5 °C for 10 h in LB medium supplemented with 50 µg/ml ampicillin, 34 µg/ml chloramphenicol, and 1% (w/v) lactose, allowing constant expression of the T7 and T7/lac promoters.

Purification of Recombinant GriF—All operations were carried out at 4 °C. Cells (3.6 g, wet weight) were harvested by centrifugation and suspended in 6 ml of buffer A (50 mM sodium phosphate, pH 8.0, 0.5 M NaCl, and 10% glycerol) containing 10 mM imidazole and 2 mg/ml lysozyme. After incubation of the mixture on ice for 30 min, the cell suspension was sonicated for 3 min and then centrifuged at 10,000 x g for 10 min to remove cell debris. Polyethyleneimine was added to the supernatant to give a final concentration of 0.1% (w/v), followed by centrifugation of the mixture at 20,000 x g for 20 min. The supernatant was a crude enzyme solution used for some analyses. For further purification of GriF, the supernatant was applied to a Cu²⁺-charged HiTrap chelating HP column (1 ml; Amersham Biosciences) equilibrated with buffer A containing 10 mM imidazole. The column was successively washed with buffer A containing 10 mM imidazole and buffer B (50 mM sodium phosphate, pH 8.0) containing 50 mM imidazole, and then the materials were eluted with buffer B containing 200 mM imidazole. The eluate was applied to a HiTrap Q column (Amersham Biosciences) equilibrated with buffer B containing 200 mM imidazole, and the column was washed with the same buffer. The flow-through and wash fractions were pooled, and ammonium sulfate was added to 20% saturation. The enzyme solution was subjected to fast protein liquid chromatography with a Resource PHE column (1 ml; Amersham) equilibrated with buffer C (50 mM sodium phosphate, pH 7.2, and 20% saturated ammonium sulfate) and eluted at a flow rate of 1 ml/min. The column was washed with the same buffer for 10 min, followed by elution with a 0–100% linear gradient of buffer D (50 mM sodium phosphate, pH 7.2, and 50% (v/v) ethylene glycol) over 10 min. Proteins were quantified using a Bio-Rad protein assay kit with bovine serum albumin as the standard. Gel filtration analysis was performed using a Superdex 200 10/30 column (Amersham Biosciences) by fast protein liquid chromatography with isocratic elution in 20 mM sodium phosphate (adjusted to pH 7.2) containing 0.15 M NaCl at a flow rate of 0.2 ml/min.

Enzyme Assays—The standard reaction mixture (400 µl) consisted of 50 mM sodium phosphate, pH 7.0, 5 mM substrate, and an enzyme sample. The mixture without enzyme was preincubated at 30 °C in a cuvette, and the reaction was started by the addition of the enzyme. GriF activity was assayed by monitoring the formation of 2-aminophenoxazin-3-one (APO; ₄₃₃ = 9600 M^–1 cm^–1) from o-aminophenol as a substrate by measuring the absorbance at 433 nm on a spectrometer (Spectra Max Plus, Molecular Devices Corp.). The initial velocity was used for the calculation of activity, which was defined as the amount (moles) of substrate decreased per s at 30 °C. The tyrosinase activity of GriF and the mushroom tyrosinase was assayed by monitoring the formation of dopachrome (₄₇₅ = 3600 M^–1 cm^–1) from L-tyrosine or L-3,4-dihydroxyphenylalanine as a substrate by measuring the absorbance at 475 nm (16). One unit of GriF activity was defined as the amount of enzyme that decreased 1 nmol of substrate/s at 30 °C.

Identification of the Reaction Products from o-Aminophenol, o-Aminophenol Plus Catechol, and 3,4-AHBAL—The products were analyzed by reversed-phase HPLC. HPLC conditions were as follows: column, Senshu Pak DOCOSIL-B (4.6 x 250 mm, Senshu Kagaku); column temperature, 30 °C; and flow rate, 1 ml/min. After 10 µlofthe reaction mixture had been injected into the column equilibrated with solvent A, the column was initially developed isocratically for 3 min, followed by elution with a linear gradient from 0 to 100% solvent B over 15 min. The reaction products from o-aminophenol, o-aminophenol plus catechol, and 3,4-AHBAL were identified as APO (compound 3a) (see Fig. 2C), 2-hydroxyphenoxazin-3-one (HPO; compound 3b), and 2-aminophenoxazin-3-one-8-aldehyde (APOAL; compound 3c), respectively, on the basis of the following spectroscopic parameters. APO (compound 3a): ¹H NMR (500 MHz, Me₂SO-d₆) 7.69 (dd, 1H, J = 8.0, 1.5, ArH), 7.49 (dd, 1H, J = 8.3, 1.5 Hz, ArH), 7.45 (td, 1H, J = 7.0, 1.5 Hz, ArH), 7.38 (td, 1H, J = 7.5, 1.5, ArH), 6.36 (s, 1H, ArH), and 6.35 (s, 1H, ArH); ¹³C NMR (125 MHz, Me₂SO-d₆) 180.2 (C-3), 149.1 (C-10a), 148.1 (C-4a), 147.6 (C-2), 141.9 (C-5a), 133.4 (C-9a), 128.8 (C-7), 127.7 (C-9), 125.3 (C-8), 116.0 (C-6), 103.5 (C-1), and 98.1 (C-4); high resolution electrospray ionization time-of-flight mass spectrum, m/z 213.06874 [M + H]⁺ (calculated for C₁₂H₉N₂O₂, 2.34 mmu error). HPO (compound 3b): ¹H NMR (500 MHz, Me₂SO-d₆) 7.81 (d, 1H, J = 7.0, ArH), 7.59 (t, 1H, J = 7.5 Hz, ArH), 7.54 (d, 1H, J = 8.0 Hz, ArH), 7.44 (t, 1H, J = 7.5, ArH), 6.69 (s, 1H, ArH), and 6.43 (s, 1H, ArH); ¹³C NMR (125 MHz, Me₂SO-d₆) 180.3 (C-3), 155.7 (C-2), 149.1 (C-10a), 148.6 (C-4a), 142.6 (C-5a), 133.2 (C-9a), 131.1 (C-7), 128.9 (C-9), 125.5 (C-8), 116.2 (C-6), 106.7 (C-1), and 104.2 (C-4); high resolution electrospray ionization time-of-flight mass spectrum, m/z 214.06998 [M + H]⁺ (calculated for C₁₂H₈N₁O₃, 4.25 mmu error). APOAL (compound 3c): ¹H NMR (500 MHz, Me₂SO-d₆) 10.05 (s, 1H, CHO), 8.20 (d, 1H, J = 2.0 Hz, ArH), 7.93 (dd, 1H, J = 8.5, 1.5 Hz, ArH), 7.66 (d, 1H, J = 8.0, ArH), 6.43 (s, 1H, ArH), and 6.36 (s, 1H, ArH); ¹³C NMR (125 MHz, Me₂SO-d₆) 191.8 (CHO), 180.5 (C-3), 149.2 (C-10a), 148.6 (C-4a), 147.8 (C-2), 146.0 (C-5a), 133.9 (C-9a), 133.2 (C-8), 130.1 (C-7), 128.1 (C-9), 117.1 (C-6), 104.3 (C-1), and 98.2 (C-4); high resolution electrospray ionization time-of-flight mass spectrum, m/z 241.09174 [M + H]⁺ (calculated for C₁₃H₉N₂O₃, 30.42 mmu error).

	RESULTS

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
GriF as a Tyrosinase Homolog—We cloned and sequenced the whole gene cluster for the biosynthesis of grixazone from S. griseus IFO13350 (Fig. 1A).² The gene cluster contains 13 open reading frames. Of the 13 gene products, two proteins (GriE and GriF) are similar to the MelC1 and MelC2 proteins, respectively, both of which are responsible for melanin biosynthesis in streptomycetes (17–21). MelC2 tyrosinase belongs to the type 3 copper protein family, and MelC1 serves as a copper chaperon for MelC2. Although tyrosinases from various organisms from bacteria to human have different secondary and tertiary structures and domain structures, they all contain two copper-binding sites, each formed by three histidine residues (Fig. 1B). The two copper-binding sites of GriF are also highly conserved. Therefore, GriF was expected to contain two copper atoms. The two closely spaced copper atoms, each coordinated by three histidine residues, must compose a binuclear copper active site of GriF, as is found for the type 3 copper proteins. Thus, because of the high end-to-end similarity (50% identity) to MelC2, GriF was expected to show monophenolase and/or diphenolase activity by the same catalytic mechanism as tyrosinases do by using molecular oxygen as an oxidizing agent.

View larger version (45K): [in this window] [in a new window]   FIGURE 1. Organization of the grixazone biosynthesis gene cluster (A) and alignment of amino acid sequences covering the two copper-binding sites (CuA and CuB) of GriF and tyrosinase family members (B). A, the 1.1 kb-region covering the griE-griF region was deleted by double reciprocal crossover. The correct deletion was checked by Southern hybridization with the 0.5-kb fragment as a 32P-labeled probe. wt, wild type. B, the three histidine residues () responsible for copper binding by each copper-binding site and the position (•) corresponding to Phe261 of Ipomoea batatas catechol oxidase I (IbCO; GenBankTM accession number Q9ZP19 (28)) are indicated. The tyrosinases aligned are from S. antibioticus (SaMelC2; accession number B23971 [GenBank] (17)), S. castaneoglobisporus (ScMelC2; accession number AAP33665 [GenBank] (20)), S. glaucescens (SgMelC2; accession number A24089 (18)), Streptomyces lavendulae (SlMelC2; accession number 2113331B (21)), N. crassa (NcTYR; accession number YRNC (37)), mushroom (Agaricus bisporus; AbTYR; accession number CAA59432 [GenBank] (38)), and Homo sapiens (HsTYR; accession number NP_000363 [GenBank] (39)).

Accumulation of 3,4-AHBAL and 3,4-AcAHBAL in S. griseus Mutant griEF—Because some tyrosinases show the ability to convert o-aminophenols into the corresponding phenoxazinone moieties, in addition to their intrinsic tyrosinase activity (12, 13), we expected that a mutation in griF would result in accumulation of o-aminophenol(s) as a substrate of GriF for the formation of the phenoxazinone chromophore of grixazone. We deleted the griEF locus on the chromosome of S. griseus IFO13350 to determine the chemical structure of a possible substrate for GriF or an intermediate in the grixazone biosynthetic pathway (Fig. 1A). As a result of double-reciprocal crossover, a 1.1-kb griEF locus (corresponding to the region from Met³ of GriE to His²²⁶ of GriF) was deleted, which was confirmed by Southern hybridization with the 0.5-kb PmaCI-SphI fragment (shown in Fig. 1A) as a ³²P-labeled probe against the chromosomal DNA digested with SphI (data not shown).

HPLC analysis of the culture broth of mutant griEF revealed the accumulation of some compounds different from grixazones. After 3 days of cultivation, mutant griEF accumulated two major compounds (2a and 2b) that were not seen in the culture broth of the parental strain when detected by absorbance at 254 nm (Fig. 2, A and B). After 5 days of cultivation, the parental strain accumulated grixazone A (compound 1a) when detected by absorbance at 433 nm, characteristic for phenoxazinones, whereas no accumulation of compound 1a was observed for mutant griEF (Fig. 2, A and B).

For experimental convenience in purification and structural determination of the compounds that accumulated in mutant griEF, we introduced griR under the control of a foreign promoter on the high copy number plasmid pIJ702 into mutant griEF because GriR (the pathway-specific transcriptional activator for the grixazone biosynthesis genes) activates the transcription of all the grixazone biosynthesis genes and because overexpression of griR leads to enhancement of the yield of grixazones.² The plasmid we constructed was pIJ702-griR, in which griR under the control of the melC promoter would be expressed in the late exponential and stationary phases. The copy number of pIJ702 is 40–300/chromosome (14). S. griseus griEF harboring pIJ702-griR produced compounds 2a and 2b in larger amounts during 3–5 days of cultivation. The amounts of these compounds were 5-fold as large as those produced by mutant griEF. After purification of compounds 2a and 2b by HPLC, their structures were determined to be 3,4-AHBAL (compound 2a) (Fig. 2C) and 3,4-AcAHBAL (compound 2b)by ¹H and ¹³C NMR and high resolution electrospray ionization time-of-flight mass spectrometry. These findings suggest that compound 2a or 2b or both serve as a substrate of GriF, as we had expected.

Production of GriE and GriF in E. coli—The apo forms of MelC2 tyrosinases responsible for melanin production in S. antibioticus (22) and Streptomyces castaneoglobisporus (16), forming a stable complex with MelC1, are usually copurified with MelC1. For production of the copper-containing active form of GriF, we constructed pET-griEF, which contained griE under the control of the T7 promoter and griF under the control of the T7/lac promoter, and pET-griF, which contained griF under the control of the T7/lac promoter. We also constructed pET-griE as a negative control, which contained griE under the control of the T7 promoter. The GriF protein encoded by these plasmids would have the structure of GriF-Leu-Glu-His₆. Both the T7 and T7/lac promoters in E. coli BL21(DE3)/pLysS were inducible by lactose in the medium. Crude lysates of E. coli harboring pET-griEF and pET-griF showed the activity to convert o-aminophenol into APO (compound 3a) (Fig. 2C), whereas no such activity was detected in a crude lysate prepared from E. coli harboring pET-griE. The structural elucidation of APO, which was produced by an in vitro reaction of GriF with o-aminophenol, will be described below. The reaction yielding APO from o-aminophenol is shown in Fig. 3B. The specific activities of the lysates from E. coli harboring pET-griEF and pET-griF were 0.060 ± 0.003 and 0.0035 ± 0.0003 units/mg of protein, respectively.

View larger version (20K): [in this window] [in a new window]   FIGURE 2. HPLC chromatograms of culture broths prepared from the wild-type strain (S. griseus IFO13350) and mutant griEF (A and B) and the chemical structures of grixazones and related compounds (C). A, the culture broth of the wild-type strain after 3 days of cultivation at 26.5 °C in SMM medium was analyzed by measuring the absorbance at 254 nm. In the inset, the HPLC profile for the culture broth after 5 days (measured by absorbance at 433 nm) is shown. B, the culture broth of mutant griEF after 3 days of cultivation at 26.5 °C in SMM medium was analyzed by measuring the absorbance at 254 nm. In the inset, the HPLC profile for the culture broth after 5 days (measured by absorbance at 433 nm) is shown. AUFS, absorbance units full scale. C, the structures of grixazones, 3,4-AHBAL, 3,4-AcAHBAL, and related compounds are shown.

Because of the contamination of GriE in the GriF preparation, we produced GriF alone in E. coli and purified it by three steps of chromatography, including Cu²⁺-charged HiTrap chelating HP affinity column chromatography, on the assumption that histidine-tagged GriF would bind to the Cu²⁺-bound affinity column through the histidine tag, incorporate Cu²⁺ into apo-GriF to form the active form, and be eluted by 200 mM imidazole, as is observed for the tyrosinase of S. castaneoglobisporus (16). As expected, the Cu²⁺-bound HiTrap column chromatography step extraordinarily increased the specific activity (Table 1). The GriF enzyme thus purified gave a single protein band of 36 kDa upon SDS-PAGE (Fig. 4A). Because the GriF preparation showed a specific activity of 65.8 ± 2.6 units/mg of protein, which was almost same as that of the purified enzyme from E. coli harboring pET-griEF, we used this sample for further study.

View larger version (18K): [in this window] [in a new window]   FIGURE 3. Catalytic properties of GriF. A, a putative pathway of coupling o-aminophenols. GriF catalyzes the oxidation of o-aminophenols to yield the corresponding quinone imines, which then non-enzymatically couple with another molecule of the quinone imine. B, GriF yields APO (compound 3a) from o-aminophenol as a result of homogeneous coupling. The coexistence of catechol in the GriF reaction with o-aminophenol results in the formation of HPO (compound 3b) as a result of heterogeneous coupling, in addition to APO (compound 3a). C, in vitro synthesis of grixazone A (compound 1a)by GriF in the presence of 3,4-AHBAL (compound 2a) as a substrate and N-acetylcysteine (NAC) as an –SH group-containing compound.

We determined the effects of metals on GriF activity. Our attempts to determine the copper content using atomic absorption were hampered by some improperly folded enzyme and potentially the His tag. The very faint activity of the lysate prepared from E. coli harboring pET-griF was ascribed to the absence of copper ions from GriF. The addition of 10 mM Cu²⁺ specifically increased the GriF activity in the lysate by 20-fold, but Zn²⁺, Ni²⁺, Co²⁺, Mn²⁺, Fe²⁺, or Mg²⁺ exerted almost no effects. Metal-chelating agents (10 mM EDTA and o-phenanthroline) had negligible effects on the purified GriF sample. This means that the two copper ions in the active site of GriF are resistant to these chelating agents, as was found for the tyrosinase from mushroom (25).

View larger version (26K): [in this window] [in a new window]   FIGURE 4. Properties of GriF. A, SDS-PAGE of the GriF sample purified from E. coli BL21(DE3)/pLysS harboring pET-griF. Myosin (200 kDa), -galactosidase (116 kDa), bovine serum albumin (66 kDa), ovalbumin (45 kDa), carbonic anhydrase (31 kDa), soybean trypsin inhibitor (21 kDa), lysozyme (14 kDa), and bovine aprotinin (6 kDa) were used for molecular mass standards. B, competitive inhibition of the GriF reaction with o-aminophenol by p-hydroxybenzaldehyde. The concentrations of the inhibitor were 0 mM (•), 0.5 mM (), 1.0 mM (), 2.5 mM (), 5.0 mM (), and 10 mM (). C, enzymatic properties of GriF. Standard reaction mixtures containing 0.0043 units of GriF were incubated at 30 °C for 7 min at various pH values (panel a) or at various temperatures for 7 min at pH 7.0 (panel b), and the amounts of the APO formed were measured. The buffers used in panels a and c were 50 mM sodium phosphate and 50 mM sodium citrate at pH 4–11 and 50 mM sodium phosphate, respectively. After GriF had been kept at 60 °C for 20 min at various pH values, the GriF activity was assayed at 30 °C for 7 min at pH 7.0 by measuring the amounts of APO formed (panel c). After GriF had been kept at various temperatures for 20 min at pH 7.0, the GriF activity was measured at 30 °C for 7 min at pH 7.0 (panel d).

GriF did not use some benzoic compounds such as p-hydroxybenzaldehyde, L-tyrosine, 4-hydroxy-3-nitrobenzaldehyde, o-nitrophenol, aniline, phenol, and 3-amino-4-hydroxybenzenesulfonic acid. We determined the conversion of o-aminophenol into APO in the presence of these compounds. Of these compounds, p-hydroxybenzaldehyde showed the most potent competitive inhibition (Fig. 4B and Table 2). 4-Hydroxy-3-nitrobenzaldehyde (which contains a nitro group at the 3-position) also showed significant competitive inhibition. We therefore concluded that these compounds were bound in the active site of GriF. Interestingly, L-tyrosine (a non-substrate of GriF) showed significant competitive inhibition. On the other hand, 3-amino-4-hydroxybenzenesulfonic acid showed a very high K_i value, suggesting that it cannot be bound strongly in the active site of GriF.

Heterodimerization—As described above, GriF produced APO when o-aminophenol was used as a substrate. We determined whether heterogeneous dimerization occurs when catechol is present in the GriF reaction with o-aminophenol. In the presence of o-aminophenol alone, GriF gave a single product of APO (compound 3a) (Fig. 5A, panel a). However, the coexistence of catechol yielded an additional product (compound 3b) (Fig. 5A, panel b), which was identified to be HPO (Fig. 2C) by ¹H and ¹³C NMR and mass spectrometry. The coexistence of catechol in the GriF reactions with 3,4-AHBAL, 3-amino-4-methylphenol, 3,4-AHBA, and 4,3-AHBA also yielded a probable heterogeneously dimerized product, in addition to the homogenously dimerized product (data not shown). However, the coexistence of phenol or aniline did not yield any product other than APO in the GriF reaction with o-aminophenol, as determined by following the absorbance from 210 to 490 nm by HPLC (Fig. 5A, panels c and d).

In Vitro Production of Grixazone A by GriF—In the oxidation of catechin by tyrosinases and peroxidases in the presence of –SH compounds (e.g. glutathione), the o-quinones produced are non-enzymatically conjugated to glutathione, resulting in the formation of catechin-glutathione conjugates (26). We therefore supposed that, in the grixazone biosynthetic pathway, the N-acetylcysteine moiety would be introduced in the quinone imine produced from 3,4-AHBAL by GriF by non-enzymatic conjugation via the –SH group. In the reaction of GriF with 5 mM 3,4-AHBAL, peak 4 in Fig. 5B (panel b) gradually increased until 30 min, and peak 3c appeared thereafter. The compound in peak 3c was identified to be APOAL (compound 3c)by ¹H and ¹³C NMR and mass spectrometry. The compound in peak 4 was presumed to be the quinone imine derived from 3,4-AHBAL because its m/z was 135.03334 [M]⁺, as determined by high resolution electrospray ionization time-of-flight mass spectrometry (calculated for C₇H₅N₁O₂, 1.31 mmu error). The quinone imine was detected in the culture broth of S. griseus, excluding the possibility that this compound is an artifact produced by the in vitro reaction. When 1 mM N-acetylcysteine was present in the GriF reaction with 3,4-AHBAL, a new peak 1a appeared, in addition to peaks 3c and 4 (Fig. 5B, panel c). The compound in peak 1a had the same retention time upon HPLC and the same UV-visible spectrum as grixazone A (compound 1a) (Fig. 5B, panel a). N-Acetylcysteine (a reducing agent) inhibited the GriF reaction, and it completely inhibited the reaction at a high concentration (5 mM). The addition of N-acetylcysteine occurred before the dimerization to form APOAL because no addition of N-acetylcysteine in the reaction mixture containing APOAL instead of 3,4-AHBAL was detected (Fig. 5B, panel e). The reaction of GriF with o-aminophenol in the presence of N-acetylcysteine is illustrated in Fig. 3C.

	DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
Functions of GriF and GriE—GriF encoded within the grixazone biosynthesis gene cluster has been found to be responsible for the formation of the phenoxazinone chromophore of grixazone by oxidative coupling of o-aminophenols. GriF is incapable of oxidation of L-tyrosine, even though it shows 50% identity in amino acid sequence to the tyrosinases responsible for melanin production in streptomycetes. Like other MelC2 tyrosinases in streptomycetes, GriF perhaps accepts copper ions from GriE, a homolog of the MelC1 copper chaperon. This is the first report to describe the enzyme system responsible for the in vivo formation of a phenoxazinone skeleton. Streptomycetes produce a variety of secondary metabolites with a phenoxazinone chromophore, and some of the tyrosinase homologs are supposed to be responsible for the formation of phenoxazinones. Because the biosynthesis genes for a given secondary metabolite are usually organized as a gene cluster, we can predict that a tyrosinase homolog encoded within the gene cluster for a secondary metabolite containing a phenoxazinone chromophore is involved in the formation of the phenoxazinone. We can safely say that the phenoxazinone chromophores of michigazone, 4-demethoxymichigazone, exfoliazone, and texazone (all with a functional group at the 8-position) are formed from o-aminophenol derivatives by the action of GriF homologs.

View larger version (27K): [in this window] [in a new window]   FIGURE 5. HPLC analysis of the products formed by the action of GriF on various substrates. A, heterogeneous coupling between the quinone imine and catechol. Standard reaction mixtures containing 5 mM each substrate were incubated at 30 °C for 1 h and subjected to HPLC. The reaction mixtures contained o-aminophenol alone (panel a), o-aminophenol and catechol (panel b), o-aminophenol and phenol (panel c), and o-aminophenol and aniline (panel d). The coexistence of catechol yielded HPO (compound 3b), in addition to APO (compound 3a). B, in vitro synthesis of grixazone A by GriF from 3,4-AHBAL and N-acetylcysteine. The standard reaction mixtures containing 5 mM 3,4-AHBAL and 1 mM N-acetylcysteine were incubated at 30 °C for 1 h and subjected to HPLC. Panel a, an authentic sample of grixazone A is shown. Panel b, GriF yielded peak 4 (containing the quinone imine), in addition to APOAL (compound 3c). Panel c, the presence of 3,4-AHBAL and N-acetylcysteine resulted in the formation of grixazone A (compound 1a), in addition to the quinone imine (compound 4) and APOAL (compound 3c). Panel d, the reaction mixture without GriF (used as a negative control) yielded no products. Panel e, the reaction mixture containing 1 mM N-acetylcysteine and 0.1 mM APOAL (compound 3c) did not yield grixazone A (compound 1a). AUFS, absorbance units full scale.

Second, GriF shows no monophenolase activity, whereas tyrosinases show monophenolase activity. Like GriF, catechol oxidase shows diphenolase activity, but not monophenolase activity (28, 31, 32). On the basis of a paramagnetic study of the interaction between the monophenolic inhibitor p-nitrophenol and the tyrosinase from S. antibioticus, together with x-ray crystallography of a plant catechol oxidase, Tepper et al. (32) proposed that the phenyl ring of Phe²⁶¹ of catechol oxidases prevents the ortho-protons of the substrate phenolic ring from its direct approach toward the catalytic center. In fact, an amino acid alignment of various catechol oxidases and tyrosinases shows that a Phe residue analogous to Phe²⁶¹ of catechol oxidases is absent in tyrosinases. Interestingly, the amino acid corresponding to Phe²⁶¹ in GriF is Tyr, which also has a phenyl ring as a side chain (Fig. 1B). The absence of monophenolase activity in GriF may be ascribed to the blocking activity of this Tyr residue.

Third, GriF activity to oxidize o-aminophenols depends on the functional group at the para-position to the phenolic hydroxyl group. The k_cat/K_m value for 2-amino-4-methylphenol (which contains a –CH₃ group at this position) was similar to that for 3,4-AHBAL (which contains a –CHO group), whereas that for o-aminophenol (which contains no functional group at this position) was decreased by 4.1-fold mainly due to an increase in the K_m value. Furthermore, the k_cat/K_m value for 3,4-AHBA (which contains a –COOH group at this position) was decreased by 130-fold compared with that for 3,4-AHBAL. GriF showed no activity for 3-amino-4-hydroxybenzenesulfonic acid (which contains an –SO₃H group at this position). The kinetic parameters for diphenols showed a tendency similar to those for o-aminophenols; the k_cat/K_m values for 3,4-dihydroxybenzaldehyde (which contains a –CHO group at the corresponding position) were 3 and 150 times larger than those for catechol (which contains no functional group at this position) and that for protocatechuic acid (which contains a –COOH group), respectively. Therefore, the functional group at the para-position with respect to the hydroxyl group of o-aminophenol is important in binding to GriF, and a –CHO group at this position is optimum for the GriF reaction. GriF appears to dislike compounds containing a negatively charged group at this position. X-ray crystallography of GriF as well as a tyrosinase will shed light on these unique properties in the substrate specificity and catalysis of GriF.

Putative Model for the Coupling of o-Aminophenols—The phenoxazinone synthase (an oligomeric multi-copper oxidase) from S. antibioticus catalyzes the oxidative condensation of two molecules of 4-methyl-3-hydroxyanthranilic acid to actinocin in vitro, the phenoxazinone chromophore of actinomycin D (33). The mechanism for the reaction was studied by blocking the reaction at various stages with substituted o-aminophenols (33). According to this mechanism, o-aminophenols are converted by two-electron oxidation to the highly electrophilic quinone imines, which then conjugate to another molecule of the o-aminophenols in the catalytic site of the enzyme. The coupling is initiated by a nucleophilic attack on the carbon at the para-position with respect to the ketone group of the quinone imine by the amino group of the o-aminophenol. The conjugates are further oxidized non-enzymatically by two electrons to yield the p-quinone imines. The second intramolecular conjugation of the p-quinone imine, followed by a final two-electron oxidation to give the phenoxazinone chromophore, occurs non-enzymatically out of the active site. On the other hand, Simandi et al. (34) analyzed the kinetics and mechanism of the ferroxime(II)-catalyzed biomimetic oxidation of o-aminophenol by dioxygen as a functional phenoxazinone synthase model. Because a 4-substituted 2-aminophenoxyl free radical was detected using the ESR technique as a reaction intermediate, they proposed a model in which two molecules of the quinone imine produced from o-aminophenol were coupled. Do quinone imines react with o-aminophenols or another molecule of quinone imines in the formation of phenoxazinones through the oxidation of o-aminophenols by GriF? If the coupling of o-aminophenol by GriF is initiated by the nucleophilic attack on the carbon at the para-position with respect to the ketone group of the quinone imine by the amino group of the o-aminophenol, the presence of aniline in the GriF reaction with o-aminophenol would yield an aniline-quinone imine conjugate (Fig. 3B). If the coupling is initiated by the electrophilic attack on the carbon at the para-position with respect to the hydroxy group of o-aminophenol by the imino group of the quinone imine, the presence of phenol in the GriF reaction with o-aminophenol would yield phenoxazin-3-one and/or its reaction intermediate (Fig. 3B). However, no such conjugates were produced. On the other hand, the presence of catechol (a substrate of GriF) resulted in the formation of a conjugate, HPO (compound 3b) (Fig. 3B). We therefore speculate that the coupling of two molecules of o-aminophenol in the GriF reaction occurs between two molecules of the quinone imine produced (Fig. 3A). GriF catalyzes only the oxidation of o-aminophenols to yield the corresponding quinone imines, and the coupling perhaps occurs non-enzymatically out of the active site, unlike the phenoxazinone synthase. Consistent with this idea, when 3,4-AHBAL was used as a substrate, an overwhelmingly larger number of quinone imine molecules compared with GriF molecules were produced during an early stage of the reaction, and then the phenoxazinone began to be produced (Fig. 5B).

The oxidation of 3,4-AHBAL and 3,4-AHBA by GriF gave APOAL and APOC, respectively. In this reaction, the –CHO or –COOH group of one of the two substrate molecules was lost. A similar observation was reported by Hughes et al. (35); 4,3-AHBA in a minimal medium was oxidized non-enzymatically to yield 2-aminophenoxazin-3-one-7-carboxylate with the loss of a –COOH group. We also observed the formation of APOC when 10 mM 3,4-AHBA in 50 mM sodium phosphate buffer, pH 7.0, was shaken vigorously at 30 °C for 12 h (data not shown), showing that the formation of APOC from 3,4-AHBA accompanied by the loss of the –COOH group of one of the two 3,4-AHBA molecules can occur non-enzymatically. The formation of APOAL from 3,4-AHBAL is also presumed to occur non-enzymatically, although the reaction is much slower.

Role of GriF in Grixazone Biosynthesis—S. griseus mutant griEF accumulates 3,4-AHBAL, which is the substrate of GriF. We have identified GriCD to be responsible for the reduction of 3,4-AHBA to yield 3,4-AHBAL.² These findings support the prediction of Gould et al. (36) that the phenoxazinones of michigazone, exfoliazone, and 4-demethoxymichigazone might be synthesized from 3,4-AHBA. Our in vitro synthesis of grixazone A from N-acetylcysteine and 3,4-AHBAL in the presence of GriF (Fig. 5B, panel c) gives us a hint to establish the biosynthetic pathway of grixazone (Fig. 3C) on the basis of the organization of the grixazone biosynthesis genes. Because grixazone A is not formed from N-acetylcysteine and APOAL in the presence of GriF (Fig. 5B, panel e), the addition of N-acetylcysteine to the quinone imine derived from oxidation of 3,4-AHBAL by two electrons occurs before its dimerization with another molecule of the quinone imine. In the oxidation of catechin by tyrosinases and peroxidases in the presence of –SH compounds (e.g. glutathione), the o-quinones produced are non-enzymatically conjugated to glutathione, resulting in the formation of catechin-glutathione conjugates (26). We therefore assume that, in the grixazone biosynthetic pathway, the quinone imine produced from 3,4-AHBAL by GriF is non-enzymatically conjugated by the –SH group of N-acetylcysteine and is then dimerized with another quinone imine, resulting in the formation of grixazone A. The non-enzymatic conjugation of N-acetylcysteine to the quinone imine is consistent with the fact that, within the grixazone biosynthesis gene cluster, there is no plausible gene encoding an enzyme able to attach N-acetylcysteine to the phenoxazinone skeleton.

Grixazone B (compound 1b) (Fig. 2C) was not formed from N-acetylcysteine and 3,4-AHBA in the presence of GriF, although APOC (compound 3d) was formed (data not shown). The coupling of the quinone imines produced from 3,4-AHBA by the action of GriF is rather rapid, although that of the quinone imines produced from 3,4-AHBAL is slow. This may facilitate the introduction of N-acetylcysteine to the quinone imine from 3,4-AHBAL. Therefore, the conversion from 3,4-AHBA to 3,4-AHBAL is important in grixazone biosynthesis. The substrate specificity of GriF (unfavorable to compounds with a negatively charged substituent at the para-position with respect to the hydroxyl group of o-aminophenols) supposedly restrains the formation of a shunt product (APOC) as a result of oxidation of 3,4-AHBA by GriF in the biosynthesis of grixazone.

	FOOTNOTES

 
^* This work was supported by Grant 03A07002 from the Industrial Technology Research Grant Program in 2003 of the New Energy and Industrial Technology Development Organization of Japan, by a grant-in-aid for scientific research on priority areas from Monkasho, and by the BioDesign Program of the Ministry of Agriculture, Forestry, and Fisheries of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBank^TM/EBI Data Bank with accession number(s) AB214954 [GenBank] .

¹ To whom correspondence should be addressed. Tel.: 81-3-5841-5123; Fax: 81-3-5841-8021; E-mail: asuhori{at}mail.ecc.u-tokyo.ac.jp.

² T. Higashi, Y. Ohnishi, and S. Horinouchi, unpublished data.

³ The abbreviations used are: 3,4-AHBAL, 3-amino-4-hydroxybenzaldehyde; 3,4-AcAH-BAL; 3-acetylamino-4-hydroxybenzaldehyde; HPLC, high performance liquid chromatography; APO, 2-aminophenoxazin-3-one; HPO, 2-hydroxyphenoxazin-3-one; APOAL, 2-aminophenoxazin-3-one-8-aldehyde; 3,4-AHBA, 3-amino-4-hydroxybenzoic acid; APOC, 2-aminophenoxazin-3-one-8-carboxylate; 4,3-AHBA, 4-amino-3-hydroxybenzoic acid; mmu, millimass unit.

	ACKNOWLEDGMENTS

 
We thank Shohei Sakuda for advice in the structure analysis of 3,4-AHBAL.

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 

1. Horinouchi, S. (2002) Front. Biosci. 7, d2045–d2057[Medline] [Order article via Infotrieve]
2. Ohnishi, Y., and Horinouchi, S. (2004) Biofilms 1, 319–328[CrossRef]
3. Ohnishi, Y., Furusho, Y., Higashi, T., Chun, H.-K., Furihata, K., Sakuda, S., and Horinouchi, S. (2004) J. Antibiot. (Tokyo) 57, 218–223[Medline] [Order article via Infotrieve]
4. Axel, Z., Sabine, B.-M., Susanne, G., Hartmut, V., and Gerhard, S. (March 23, 1988) European Patent EP260486
5. Arison, B. H., and Hoogsteen, K. (1970) Biochemistry 9, 3976–3983[Medline] [Order article via Infotrieve]
6. Wolf, G., Worth, J., and Achenbach, H. (1975) Arch. Microbiol. 106, 245–249[Medline] [Order article via Infotrieve]
7. Gerber, N. N., Yale, H. L., Taber, W. A., Kurobane, I., and Vining, L. C. (1983) J. Antibiot. (Tokyo) 36, 688–694[Medline] [Order article via Infotrieve]
8. Imai, S., Shimazu, A., Furihata, K., Furihata, K., Hayakawa, Y., and Seto, H. (1990) J. Antibiot. (Tokyo) 43, 1606–1607[Medline] [Order article via Infotrieve]
9. Kunigami, T., Shin-ya, K., Furihata, K., Furihata, K., Hayakawa, Y., and Seto, H. (1996) J. Antibiot. (Tokyo) 49, 312–313[Medline] [Order article via Infotrieve]
10. Hsieh, C.-J., and Jones, G. H. (1995) J. Bacteriol. 177, 5740–5747[Abstract/Free Full Text]
11. Jones, G. H. (2000) Antimicrob. Agents Chemother. 44, 1322–1327[Abstract/Free Full Text]
12. Toussaint, O., and Lerch, K. (1987) Biochemistry 26, 8567–8571[CrossRef][Medline] [Order article via Infotrieve]
13. Gasowska, B., Kafarski, P., and Wojtasek, H. (2004) Biochim. Biophys. Acta 1673, 170–177[Medline] [Order article via Infotrieve]
14. Hopwood, D. A., Bibb, M. J., Chater, K. F., Kieser, T., Bruton, C. J., Kieser, H. M., Lydiate, D. J., Smith, C. P., Ward, J. M., and Schrempf, H. (1985) Genetic Manipulation in Streptomyces: A Laboratory Manual, The John Innes Foundation, Norwich, UK
15. Maniatis, T., Fritsch, E. F., and Sambrook, J. (1982) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
16. Kohashi, Y. P., Kumagai, T., Matoba, Y., Yamamoto, A., Maruyama, M., and Sugiyama, M. (2004) Protein Expression Purif. 34, 202–207[CrossRef][Medline] [Order article via Infotrieve]
17. Bernan, V., Filpula, D., Herber, W., Bibb, M., and Katz, E. (1985) Gene (Amst.) 37, 101–110[CrossRef][Medline] [Order article via Infotrieve]
18. Huber, M., Hintermann, G., and Lerch, K. (1985) Biochemistry 24, 6038–6044[CrossRef][Medline] [Order article via Infotrieve]
19. Hintermann, G., Zatchej, M., and Hütter, R. (1985) Mol. Gen. Genet. 200, 422–432[CrossRef][Medline] [Order article via Infotrieve]
20. Ikeda, K., Masujima, T., Suzuki, K., and Sugiyama, M. (1992) Appl. Microbiol. Biotechnol. 45, 80–85
21. Kawamoto, S., Nakamura, M., and Yashima, S. (1993) J. Ferment. Bioeng. 76, 345–355[CrossRef]
22. Schaerlaekens, K., Schierová, M., Lammertyn, E., Geukens, N., Anné, J., and van Mellaert, L. (2001) J. Bacteriol. 183, 6727–6732[Abstract/Free Full Text]
23. Chen, L.-Y., Leu, W.-M., Wang, K.-T., and Lee, Y.-H. W. (1992) J. Biol. Chem. 267, 20100–20107[Abstract/Free Full Text]
24. Chen, L.-Y., Chen, M.-Y., Leu, W.-M., Tsai, T.-Y., and Lee, Y.-H. W. (1993) J. Biol. Chem. 268, 18710–18716[Abstract/Free Full Text]
25. Jolley, R. L., Donald, J., Robb, A., and Mason, H. S. (1969) J. Biol. Chem. 244, 1593–1599[Abstract/Free Full Text]
26. Moridani, M. Y., Scobie, H., Salehi, P., and O'Brien, P. J. (2001) Chem. Res. Toxicol. 14, 841–848[CrossRef][Medline] [Order article via Infotrieve]
27. Gaykema, W. P. J., Hol, W. G. J., Vereijken, J. M., Soeter, N. M., Bak, H. J., and Beintema, J. J. (1984) Nature 309, 23–29[CrossRef]
28. Klabunde, T., Eicken, C., Sacchettini, C. J., and Krebs, B. (1998) Nat. Struct. Biol. 5, 1084–1090[CrossRef][Medline] [Order article via Infotrieve]
29. Fenoll, L. G., Peñalver, M. J., Rodríguez-López, J. N., Varón, R., García-Cánovas, F., and Tudela, J. (2004) Int. J. Biochem. Cell Biol. 36, 235–246[CrossRef][Medline] [Order article via Infotrieve]
30. Fenoll, L. G., Peñalver, M. J., Rodríguez-López, J. N., García-Ruiz, P. A., García-Cánovas, F., and Tudela, J. (2004) Biochem. J. 380, 643–650[CrossRef][Medline] [Order article via Infotrieve]
31. Siegbahn, P. E. (2004) J. Biol. Inorg. Chem. 9, 577–590[Medline] [Order article via Infotrieve]
32. Tepper, A. W., Bubacco, L., and Canters, G. W. (2005) J. Am. Chem. Soc. 127, 567–575[Medline] [Order article via Infotrieve]
33. Barry, C. E., III, Nayer, P. G., and Begley, T. P. (1989) Biochemistry 28, 6323–6333[CrossRef][Medline] [Order article via Infotrieve]
34. Simandi, T. M., Simandi, L. I., Gyor, M., Rockenbauer, A., and Gomory, A. (2004) Dalton Trans. 7, 1056–1060
35. Hughes, M. A., Baggs, M. J., Al-Dulayymi, J., Baird, M. S., and Williams, P. A. (2002) Appl. Environ. Microbiol. 68, 4965–4970[Abstract/Free Full Text]
36. Gould, S. J., Melville, C. R., and Cone, M. C. (1996) J. Am. Chem. Soc. 118, 9228–9232[CrossRef]
37. Lerch, K. (1982) J. Biol. Chem. 257, 6414–6419[Abstract/Free Full Text]
38. Wichers, H. J., Recourt, K., Hendriks, M., Ebbelaar, C. E., Biancone, G., Hoeberichts, F. A., Mooibroek, H., and Soler-Rivas, C. (2003) Appl. Microbiol. Biotechnol. 61, 336–341[Medline] [Order article via Infotrieve]
39. Kwon, B. S., Haq, A. K., Pomerantz, S. H., and Halaban, R. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 7473–7477[Abstract/Free Full Text]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				D. Lopez-Serrano, F. Solano, and A. Sanchez-Amat Involvement of a novel copper chaperone in tyrosinase activity and melanin synthesis in Marinomonas mediterranea Microbiology, July 1, 2007; 153(7): 2241 - 2249. [Abstract] [Full Text] [PDF]

				T. Higashi, Y. Iwasaki, Y. Ohnishi, and S. Horinouchi A-Factor and Phosphate Depletion Signals Are Transmitted to the Grixazone Biosynthesis Genes via the Pathway-Specific Transcriptional Activator GriR J. Bacteriol., May 1, 2007; 189(9): 3515 - 3524. [Abstract] [Full Text] [PDF]

				H. Suzuki, Y. Ohnishi, and S. Horinouchi Arylamine N-Acetyltransferase Responsible for Acetylation of 2-Aminophenols in Streptomyces griseus J. Bacteriol., March 1, 2007; 189(5): 2155 - 2159. [Abstract] [Full Text] [PDF]

				H. Suzuki, Y. Ohnishi, Y. Furusho, S. Sakuda, and S. Horinouchi Novel Benzene Ring Biosynthesis from C3 and C4 Primary Metabolites by Two Enzymes J. Biol. Chem., December 1, 2006; 281(48): 36944 - 36951. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 281/2/824    most recent M505806200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Suzuki, H. Articles by Horinouchi, S. Search for Related Content PubMed PubMed Citation Articles by Suzuki, H. Articles by Horinouchi, S. Social Bookmarking                      What's this?